Clinical Trial Update: Treatment of Aggressive Localized Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a treatment for aggressive localized B-cell lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: B Cell Lymphoma | Phase 3 | Status: TERMINATED